Panniculitis due to potassium bromide

Area of Science:

• Dermatology
• Neurology
• Toxicology

Background:

• Potassium bromide is recognized for its efficacy in treating severe myoclonic epilepsy in infants (SME).
• Rare but severe cutaneous adverse events, including febrile nodular panniculitis (Weber-Christian syndrome), have been associated with its use.

Observation:

• This paper details five cases of halogen panniculitis, a systemic disease characterized by subcutaneous nodules, fever, and potential skin necrosis.
• Histopathological examination reveals inflammation of adipose tissue with lymphocytic infiltration.

Findings:

• The etiology of halogen panniculitis remains unclear, with allergy or toxicity being suspected.
• While lymphocyte transformation tests (LTT) were not diagnostic, bromides may act as chemokines, potentially forming detrimental bromine radicals under UV irradiation.

Implications:

• Understanding the pathogenesis of halogen panniculitis is crucial for managing patients with SME on bromide therapy.
• Further research is needed to elucidate the mechanisms underlying bromide-induced panniculitis and inform safer treatment strategies.